Haotian Tang

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Assessing the Hydrogen Supply and Infrastructure Needs for China's Hard-to-Abate Sectors on Its Path to Carbon Neutrality.

Assessing the Hydrogen Supply and Infrastructure Needs for China's Hard-to-Abate Sectors on Its Path to Carbon Neutrality.

Journal: Environmental science & technology

Published: February 06, 2026

Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR Inhibitor.

Sphingosine-1-Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third-Generation EGFR Inhibitor.

Journal: MedComm

Published: July 25, 2025

Discovery of TBK1Molecular Glue Degraders as a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Discovery of TBK1Molecular Glue Degraders as a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Journal: Journal of medicinal chemistry

Published: June 06, 2025

Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.

Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.

Journal: Cancer cell international

Published: March 31, 2025

FMCW Radar Human Action Recognition Based on Asymmetric Convolutional Residual Blocks.

FMCW Radar Human Action Recognition Based on Asymmetric Convolutional Residual Blocks.

Journal: Sensors (Basel, Switzerland)

Published: June 02, 2024

A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease.

A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease.

Journal: Molecules (Basel, Switzerland)

Published: March 16, 2024

Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation.

Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation.

Journal: Signal transduction and targeted therapy

Published: November 20, 2023

Application of deep generative model for design of Pyrrolo[2,3-d] pyrimidine derivatives as new selective TANK binding kinase 1 (TBK1) inhibitors.

Application of deep generative model for design of Pyrrolo[2,3-d] pyrimidine derivatives as new selective TANK binding kinase 1 (TBK1) inhibitors.

Journal: European journal of medicinal chemistry

Published: October 31, 2022

Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Journal: European journal of medicinal chemistry

Published: October 25, 2022

ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK.

ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK.

Journal: Frontiers in pharmacology

Published: October 15, 2022

China's multi-sector-shared CCUS networks in a carbon-neutral vision.

China's multi-sector-shared CCUS networks in a carbon-neutral vision.

Journal: iScience

Published: September 29, 2022

Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo.

Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo.

Journal: Journal of Cancer

Published: August 05, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026